Inobrodib

DB17514InvestigationalSmall molecule

Inobrodib: Overview.

Also known as
(s)-1-(3,4-difluorophenyl)-6-(5-(3,5-dimethylisoxazol-4-yl)-1-((1r,4s)-4-methoxycyclohexyl)-1h-benzo(d)imidazol-2-yl)piperidin-2-one · 2-piperidinone, 1-(3,4-difluorophenyl)-6-(5-(3,5-dimethyl-4-isoxazolyl)-1-(trans-4-methoxycyclohexyl)-1h-benzimidazol-2-yl)-, (6s)- · P300/cbp bromodomain inhibitor ccs1477
Code names
CCS-1477

Resolves to

Compound
UNIIBW5QA5GEW7CAS2222941-37-7
Targets
Q92793CREBBPQ09472EP300

What you can answer from here — as of August 25, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Inobrodib, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In